期刊文献+

不同浓度地塞米松体外对人成骨细胞和破骨细胞分化的影响 被引量:2

Effect of dexamethasone on differentiation of human osteoblast and osteoclast in vitro
下载PDF
导出
摘要 目的:探讨地塞米松(DEX)体外对人成骨细胞(OBs)和破骨细胞(OCs)分化的影响。方法:以DEX为主要成分的诱导剂体外刺激正常人骨髓间充质干细胞(MSCs),茜素红染色及碱性磷酸酶(ALP)定量法检测OBs间钙结节形成及OBs中ALP水平;改变DEX浓度后,再检测ALP水平以及用Western blotting检测OBs中磷酸化GSK-3β蛋白的表达;外源性核因子κB受体活化因子配基(RANKL)刺激人骨髓单个核细胞(BMMs)14 d后,用抗酒石酸酸性磷酸酶染色鉴定OCs形成情况、Western blotting检测BMMs中RANKL下游的信号途径;不同浓度DEX刺激MSCs 7 d后,用ELISA和Western blotting检测培养液中可溶性RANKL(sRANKL)水平及MSCs中RANKL蛋白表达。结果:含0.1μmol/L DEX的诱导剂刺激MSCs后可有钙结节形成,在DEX 0.001-0.1μmol/L浓度范围内,OBs中ALP水平逐渐增高、磷酸化GSK-3β蛋白表达逐渐增强,当DEX浓度进一步增加后(0.1-10μmol/L),ALP水平和磷酸化GSK-3β蛋白表达反而下降;外源性RANKL可以诱导BMMs分化为OCs,且BMMs中磷酸化IκBα、SPAK/JNK、p38 MAPK、p44/42 MAPK表达增强;在0.001-10μmol/L浓度范围内,DEX刺激MSCs后,培养液中sRANKL水平和MSCs中RANKL蛋白表达逐渐增高,且sRANKL水平和DEX浓度呈正相关(r=0.821,P<0.05)。结论:在低浓度(0.001-0.1μmol/L)范围内,DEX既促进OBs分化,又可促进OCs分化。在高浓度(0.1-10μmol/L)范围内,仍能促进OCs分化,但失去了其对OBs的分化作用。 AIM: To investigate the effect of dexamethasone(DEX) on differentiation of human osteoblasts(OBs) and osteoclasts(OCs) in vitro.METHODS: The normal human bone marrow mesenchymal stem cells(MSCs) were stimulated with the inducer mainly containing DEX in vitro.Alizarin red staining and alkaline phosphatase(ALP) kit were used to identify the formation of calcium nodules among OBs and ALP levels in OBs,respectively.The levels of ALP were quantified again after the concentration of DEX was changed,and the expression of phosphorylated GSK-3β in OBs was detected by Western blotting.Human bone marrow mononuclear cells(BMMs) were induced by exogenous receptor activator of nuclear factor kappa B ligand(RANKL) for 14 days.Tartrate-resistant acidic phosphatase staining was used to identity the formation of OCs,and the downstream signaling pathway of RANKL was detected by Western blotting.The le-vel of soluble RANKL(sRANKL) in the supernatants and the expression of RANKL in MSCs were measured by ELISA and Western blotting,respectively,when MSCs were stimulated with different concentrations of DEX for 7 days.RESULTS: Calcium nodules were formed when MSCs were stimulated with DEX at concentration of 0.1 μmol/L.The level of ALP and the protein expression of phospho-GSK-3β in OBs gradually increased by treating the cells with DEX at the concentrations within the range of 0.001-0.1 μmol/L.However,the level of ALP and the protein expression of phospho-GSK-3β were decreased as the concentrations of DEX further increased to the range of 0.1-10 μmol/L.BMMs were differeniated into OCs by exogenous RANKL,and the phosphorylations of IκBα,SPAK/JNK,p38 MAPK and p44/42 MAPK in BMMs increased.When MSCs were stimulated with DEX at the concentrations within 0.001-10 μmol/L,the level of sRANKL in the supernatants and the protein expression of RANKL in MSCs gradually increased,and the level of sRANKL was positively correlated with the concentration of DEX(r=0.821,P0.05).CONCLUSION: DEX at low
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2011年第7期1393-1397,共5页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30670997) 教育部归国人员启动基金资助项目(No.2005546) 中山大学附属第一医院人才支持计划资助项目(No.18700108)
关键词 地塞米松 成骨细胞 破骨细胞 Dexamethasone Osteoblasts Osteoclasts
  • 相关文献

参考文献9

  • 1许多荣,李庆山,张祥忠,邹外一,罗绍凯,李娟,苏畅,黄珊,杨茂华.调节破骨细胞分化的RANK特异性基序的再确认[J].中国病理生理杂志,2009,25(4):764-769. 被引量:1
  • 2Xu D,Wang S,Liu W,et al.A novel receptor activator ofNF-κB(RANK)cytoplasmic motif plays an essentialrole in osteoclastogenesis by committing macrophages to theosteoclast lineage. Journal of Biological Chemistry . 2006 被引量:1
  • 3van Staa TP,Leufkens HG,Abenhaim L,et al.Use of o-ral corticosteroids and risk of fractures. Journal of Bone and Mineral Research . 2005 被引量:1
  • 4Maruotti N,Corrado A,Cantatore FP.Glucocorticoid in-duced risk of fractures. Panminerva Medica . 2010 被引量:1
  • 5Skurk C,Maatz H,Rocnik E,et al.Glycogen-synthase ki-nase 3β/β-catenin axis promotes angiogenesis throughactivation of vascular endothelial growth factor signaling inendothelial cells. Circulation Research . 2005 被引量:1
  • 6Butler JS,Queally JM,Devitt BM,et al.Silencing Dkk1expression rescues dexamethasone induced suppression ofprimary human osteoblast differentiation. BMC Muscu-loskelet Disord . 2010 被引量:1
  • 7Liu W,Xu D,Yang H,Xu H, et al.Functional identification of three receptor activator of NF-kappa B cytoplasmic motifs mediating osteoclast differentiation and function. Journal of Biological Chemistry . 2004 被引量:1
  • 8Spiro AS,Beil FT,Schinke T,et al.Short-term application of dexamethasone enhances bone morphogenetic protein-7-induced ectopic bone formation in vivo. The Journal of Trauma . 2010 被引量:1
  • 9Canalis E,Delany A M.Mechanisms of glucocorticoid action in bone. Annals of the New York Academy of Sciences . 2002 被引量:1

二级参考文献10

  • 1Xu D,Shi Z,Mcdonald J,et al.Development of a chimacric receptor approach to study signaling by tumour necrosis factor family members[J].Biochem J,2004,383(4):219-225. 被引量:1
  • 2Mountazios G,Dimopoulos MA,Bamias A,et al.Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappa B ligand(RANKL)/osteoprotegerin(OPG)axis in patients with solid tumors metastatic to the skeleton[J].Acta Oncol,2007,46(2):221-229. 被引量:1
  • 3Hsu H,Lacey DL,Dunstan CR,et al.Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand[J].Proc Natl Acad Sci USA,1999,96(7):3540-3545. 被引量:1
  • 4Darnay BG,Ni J,Moore PA,et al.Activation of NF-kappa B by RANK requires tumor necrosis factor receptor-associated factor(TRAF)6 and NF-kappa B-inducing kinase.Identification of a novel TRAF6 interaction domain[J].J Biol Chem,1999,274(12):7724-7731. 被引量:1
  • 5Tai YT,Fulciniti M,Hideshima T,et al.Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis[J].Blood,2007,110(5):1656-1663. 被引量:1
  • 6Yasuda H,Shima N,Nakagawa N,et al.Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL[J].Proc Natl Acad Sci USA,1998,95(7):3597-3602. 被引量:1
  • 7Inoue J,Ishida T,Tsukamoto N,et al.Tumor necrosis factor receptor-associated factor(TRAF)family:adapter proteins that mediate cytokine signaling[J].Exp Cell Res,2000,254(1):14-24. 被引量:1
  • 8Liu W,Xu D,Yang H,et al.Functional identification of three RANK cytoplasmic domain mediating osteoclast differentiation and function[J].J Biol Chem,2004,279(52):54759-54769. 被引量:1
  • 9Xu D,Wang S,Liu W,et al.A novel receptor activator of NF-κB(RANK)cytoplasmic motif plays an essential role in osteoclastogenesis by committing macrophages to the osteoclast lineage[J].J Biol Chem,2006,281(8):4678-4690. 被引量:1
  • 10Galibert L,Tometsko ME,Anderson DM,et al.The involvement of multiple tumor necrosis factor receptor(TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappa B,a member of the TNFR superfamily[J].J Biol Chem,1998,273(51):34120-34127. 被引量:1

同被引文献23

  • 1Li Y,LüX,Sun X,et al.Odontoblast-like cell differentiation anddentin formation induced with TGF-β1[J].Arch Oral Biol,2011,56(11):1221-1229. 被引量:1
  • 2Yuan GH,Yang GB,Wu LA,et al.Potential role of dentin sialoproteinby inducing dental pulp mesenchymal stem cell differentiation andmineralization for dental tissue repair[J].Dent Hypotheses,2010,1(2):69-75. 被引量:1
  • 3Nakashima M,Iohara K,Sugiyama M.Human dental pulp stem cellswith highly angiogenic and neurogenic potential for possible use inpulp regeneration[J].Cytokine Growth Factor Rev,2009,20(5-6):435-440. 被引量:1
  • 4Arthur A,Rychkov G,Shi S,et al.Adult human dental pulp stemcells differentiate toward functionally active neurons under appropriateenvironmental cues[J].Stem Cells,2008,26(7):1787-1795. 被引量:1
  • 5Dresser R.Stem cell research as innovation:expanding the ethicaland policy conversation[J].J Law Med Ethics,2010,38(2):332-341. 被引量:1
  • 6Taura D,Noguchi M,Sone M,et al.Adipogenic differentiation ofhuman induced pluripotent stem cells:comparison with that ofhuman embryonic stem cells[J].FEBS Lett,2009,583(6):1029-1033. 被引量:1
  • 7Yamada Y,Nakamura S,Ito K,et al.A feasibility of useful cell-based therapy by bone regeneration with deciduous tooth stem cells,dental pulp stem cells,or bone-marrow-derived mesenchymalstem cells for clinical study using tissue engineering technology[J].Tissue Eng Part A,2010,16(6):1891-1900. 被引量:1
  • 8Yu J,Wang Y,Deng Z,et al.Odontogenic capability:bone marrowstromal stem cells versus dental pulp stem cells[J].Biol Cell,2007,99(8):465-474. 被引量:1
  • 9Hilton TJ.Keys to clinical success with pulp capping:a review ofthe literature[J].Oper Dent,2009,34(5):615-625. 被引量:1
  • 10Torabinejad M,Anderson P,Bader J,et al.Outcomes of root canaltreatment and restoration,implant-supported single crowns,fixedpartial dentures,and extraction without replacement:a systematicreview[J].J Prosthet Dent,2007,98(4):285-311. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部